Lannett Receives FDA Approval for Phentermine

Lannett Company, Inc. announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental abbreviated new drug application (ANDA) of Phentermine Hydrochloride Capsules 30 mg.
FinanzNachrichten